Search research articles
Contact Us
Filters
Showing results (51-60 of 154) with videos related to
Page
of 16
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
October 15, 1986
Differential expression of lymphokine-activated killer cells and natural killer cells in adoptive transfer experiments utilizing fractionated bone marrow
V J Merluzzi, P A Trail, K Last-Barney
Journal of Wrist Surgery
|
February 7, 2020
Radiographic and Computed Tomography Correlation of Kienböck's Disease: Is There a Need to Revisit Staging with Improved Imaging?
Arvind Mohan, Richard Knight, Hiba Ismail, et al.
The Journal of Hand Surgery, European Volume
|
April 10, 2007
Twenty questions on carpal instability
I A Trail, J K Stanley, M J Hayton
Journal of Hand Surgery (Edinburgh, Scotland)
|
February 15, 2000
Cytotoxicity of cyanoacrylate adhesives to cultured tendon cells
C E Evans, G C Lees, I A Trail
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1994
Drug immunotargeting for carcinomas: a reality at last?
A M Casazza, P A Trail, K E Hellström
The Journal of Hand Surgery
|
December 14, 2011
The fixation strength of scaphoid bone screws: an in vitro investigation using polyurethane foam
Louise A Crawford, Eric S Powell, Ian A Trail
Journal of Hand Surgery (Edinburgh, Scotland)
|
October 1, 1996
A cadaveric study of the anatomy and stability of the distal radioulnar joint in the coronal and transverse planes
A R Tolat, J K Stanley, I A Trail
Pharmacology & Therapeutics
|
August 1, 2017
Antibody drug conjugates for treatment of breast cancer: Novel targets and diverse approaches in ADC design
Pamela A Trail, Gene M Dubowchik, Timothy B Lowinger
The Journal of Hand Surgery, European Volume
|
February 2, 2011
The outcome of wrist surgery: what factors are important and how should they be reported?
A Birch, D Nuttall, J K Stanley, et al.
Methods in Enzymology
|
June 8, 2006
Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature
Lila Adnane, Pamela A Trail, Ian Taylor, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 154) with videos related to
Sort By:
Page
of 16
Journal of Immunology (Baltimore, Md. : 1950)
|
October 15, 1986
Differential expression of lymphokine-activated killer cells and natural killer cells in adoptive transfer experiments utilizing fractionated bone marrow
V J Merluzzi, P A Trail, K Last-Barney
Journal of Wrist Surgery
|
February 7, 2020
Radiographic and Computed Tomography Correlation of Kienböck's Disease: Is There a Need to Revisit Staging with Improved Imaging?
Arvind Mohan, Richard Knight, Hiba Ismail, et al.
The Journal of Hand Surgery, European Volume
|
April 10, 2007
Twenty questions on carpal instability
I A Trail, J K Stanley, M J Hayton
Journal of Hand Surgery (Edinburgh, Scotland)
|
February 15, 2000
Cytotoxicity of cyanoacrylate adhesives to cultured tendon cells
C E Evans, G C Lees, I A Trail
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1994
Drug immunotargeting for carcinomas: a reality at last?
A M Casazza, P A Trail, K E Hellström
The Journal of Hand Surgery
|
December 14, 2011
The fixation strength of scaphoid bone screws: an in vitro investigation using polyurethane foam
Louise A Crawford, Eric S Powell, Ian A Trail
Journal of Hand Surgery (Edinburgh, Scotland)
|
October 1, 1996
A cadaveric study of the anatomy and stability of the distal radioulnar joint in the coronal and transverse planes
A R Tolat, J K Stanley, I A Trail
Pharmacology & Therapeutics
|
August 1, 2017
Antibody drug conjugates for treatment of breast cancer: Novel targets and diverse approaches in ADC design
Pamela A Trail, Gene M Dubowchik, Timothy B Lowinger
The Journal of Hand Surgery, European Volume
|
February 2, 2011
The outcome of wrist surgery: what factors are important and how should they be reported?
A Birch, D Nuttall, J K Stanley, et al.
Methods in Enzymology
|
June 8, 2006
Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature
Lila Adnane, Pamela A Trail, Ian Taylor, et al.
Page
of 16